Enalapril/amlodipine combination in cyclosporine‐treated renal transplant recipients: a prospective randomized trial

200731 citationsJournal Article

Authors

Jean‐Michel Halimi · Centre Hospitalier Universitaire de Tours

Bruno Giraudeau · Clinical Investigation Center Plurithematic Tours

Matthias Büchler · Centre Hospitalier Universitaire de Tours

Azmi Al‐Najjar · Université de Tours

Isabelle Étienne · Hôpital Privé Guillaume de Varye

I. Laouad · Centre Hospitalier Universitaire de Tours

F. Bruyère

Abstract

Angiotensin-converting enzyme inhibitor (ACEI)-calcium-channel blocker (CCB) combination controls arterial pressure more adequately than ACEI alone or CCB alone, reduces albuminuria and may prevent the ACEI-induced initial rise in serum creatinine.

Topics & Keywords

Blood Pressure and Hypertension Studies Pharmacological Effects and Toxicity Studies Potassium and Related Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Transplantation

Volume 21, Issue 2, pp. 277-284

DOI: 10.1111/j.1399-0012.2007.00643.x

Field-Weighted Citation Impact: 2.17